AMAG Pharmaceuticals: 3Q Earnings Snapshot

November 1, 2018

WALTHAM, Mass. (AP) _ AMAG Pharmaceuticals Inc. (AMAG) on Thursday reported third-quarter net income of $30.8 million, after reporting a loss in the same period a year earlier.

On a per-share basis, the Waltham, Massachusetts-based company said it had profit of 89 cents. Losses, adjusted for one-time gains and costs, were 77 cents per share.

The results met Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for a loss of 77 cents per share.

The specialty drugmaker posted revenue of $122.2 million in the period, surpassing Street forecasts. Six analysts surveyed by Zacks expected $117.7 million.

AMAG Pharmaceuticals expects full-year revenue in the range of $470 million to $490 million.

AMAG Pharmaceuticals shares have climbed 64 percent since the beginning of the year. The stock has increased 38 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMAG at https://www.zacks.com/ap/AMAG

All contents © copyright 2019 The Associated Press. All rights reserved.